Pelthos Therapeutics Inc.
PTHS· NYSE
Released Aug 13, 2025, after the close
10-Q filed Aug 13, 2025, 44 days after period end · 0001753926-25-001326
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$3.45M | -$1.77M | -$953.35K |
| EPS Diluted | -$5.29 | -$3.07 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR